SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Interventions for financial toxicity among cancer survivors: A scoping review
16 references·0 citing·34 second hop
Interventions for financial toxicity among cancer survivors: A scoping review (2023)Interventions for financial toxicity amon…Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050 (2023)Estimates and Projections of …Navigating financial toxicity in patients with cancer: A multidisciplinary management approach (2022)Navigating financial toxicity…Financial toxicity in cancer care: origins, impact, and solutions (2021)Financial toxicity in cancer …Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications (2019)Methods for measuring financi…Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Financial toxicity in cancer …Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes (2019)Financial Burdens of Cancer T…The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment (2018)The financial burden and dist…Relationships Between Financial Toxicity and Symptom Burden in Cancer Survivors: A Systematic Review (2018)Relationships Between Financi…PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)PRISMA Extension for Scoping …Financial Hardships Experienced by Cancer Survivors: A Systematic Review (2016)Financial Hardships Experienc…A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay (2016)A Systematic Review of Financ…The Joanna Briggs Institute reviewers' manual 2015: methodology for JBI scoping reviews (2015)The Joanna Briggs Institute r…The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)The development of a financia…Long-Term Financial Burden of Breast Cancer: Experiences of a Diverse Cohort of Survivors Identified Through Population-Based Registries (2014)Long-Term Financial Burden of…Financial toxicity, Part I: a new name for a growing problem. (2013)Financial toxicity, Part I: a…Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care? (2013)Are survivors who report canc…An Index of Factorial Simplicity (1974)Constructing validity: Basic issues in objective scale development. (1995)Methods for the Economic Evaluation of Health Care Programmes (2005)Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors (2015)Marriage protection and marriage selection—Prospective evidence for reciprocal effects of marital status and health (1996)The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)Population-Based Assessment of Cancer Survivors' Financial Burden and Quality of Life: A Prospective Cohort Study (2015)Self‐reported financial burden of cancer care and its effect on physical and mental health‐related quality of life among US cancer survivors (2016)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence (2014)Stress: Appraisal and Coping (2013)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (2013)Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)Scoping studies: towards a methodological framework (2005)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Scoping studies: advancing the methodology (2010)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal (2024)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Cochrane Handbook for Systematic Reviews of Interventions (2019)Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review (2020)Handbook of The Economics of Education (2011)A new data set of educational attainment in the world, 1950–2010 (2012)Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)How Non-Native Writers Realize Their Interpersonal Meaning? (2018)Unleashing the power of innovation promoters for sustainable economic growth: a global perspective (2023)The global macroeconomic burden of diabetes mellitus (2025)Understanding the relationship between teachers’ pedagogical beliefs and technology use in education: a systematic review of qualitative evidence (2016)Perinatal health outcomes and care among asylum seekers and refugees: a systematic review of systematic reviews (2018)The benefits of and barriers to using a social robot PARO in care settings: a scoping review (2019)
this work references cited by second hop

References

  • 2018PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation45,728 cited
  • 2015The Joanna Briggs Institute reviewers' manual 2015: methodology for JBI scoping reviews1,137 cited
  • 2023Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050908 cited
  • 2018The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment873 cited
  • 2016Financial Hardships Experienced by Cancer Survivors: A Systematic Review861 cited
  • 2014The development of a financial toxicity patient‐reported outcome in cancer: The COST measure692 cited
  • 2013Financial toxicity, Part I: a new name for a growing problem.502 cited
  • 2016A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay480 cited
  • 2019Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes442 cited
  • 2013Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care?412 cited
  • 2019Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies337 cited
  • 2014Long-Term Financial Burden of Breast Cancer: Experiences of a Diverse Cohort of Survivors Identified Through Population-Based Registries277 cited
  • 2019Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

274 cited
  • 2022Navigating financial toxicity in patients with cancer: A multidisciplinary management approach264 cited
  • 2021Financial toxicity in cancer care: origins, impact, and solutions252 cited
  • 2018Relationships Between Financial Toxicity and Symptom Burden in Cancer Survivors: A Systematic Review203 cited
  • Cited by

    No citing works inside the corpus for this window.